4//SEC Filing
GRAINGER DAVID J 4
Accession 0000899243-22-004682
CIK 0001847903other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:30 PM ET
Size
5.9 KB
Accession
0000899243-22-004682
Insider Transaction Report
Form 4
GRAINGER DAVID J
Chief Innovation Officer
Transactions
- Award
Share Option (right to buy)
2022-02-01+200,000→ 200,000 totalExercise: $9.53Exp: 2032-02-01→ Ordinary Shares (200,000 underlying)
Footnotes (2)
- [F1]33,328 shares subject to such option shall vest and become exercisable on October 1,2022 and the remaining 166,672 shares subject to such option shall vest and become exercisable in 40 substantially equal installments on each monthly anniversary thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001887115
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:30 PM ET
- Size
- 5.9 KB